$RNLXY Cashflow Statement | Understand Stock

$RNLXY

$4.15 -$0.33 (7.47%) Close

$RNLXY Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2024 12 months to Jun 30, 2024	FY2023 12 months to Jun 30, 2023	FY2022 12 months to Jun 30, 2022	FY2021 12 months to Jun 30, 2021
Cash flows from operating activities:
Net Income Loss
Adjustments to reconcile net loss to net cash used in operating activities
Gain on VericiDx deconsolidation
Depreciation and amortization
Impairment loss on property, equipment and other long-lived assets
Stock-based compensation
Gain on loan
Realized gain on short-term investments
Equity in losses of affiliate
Reduction of Kantaro liability
Fair value adjustment to VericiDx investment
Unrealized foreign exchange gain
Realized loss on sale of ordinary shares in VericiDx
Realized foreign exchange gain
Fair value adjustment to convertible Debt
Fair value adjustment to convertible debt, net interest paid
Non cash lease expense

Changes in operating assets and liabilities:
Accounts receivable
Prepaid expenses and other current assets
Related party receivable
Receivable from affiliates
Accounts payable
Accounts payable - related party
Accrued expenses and other current liabilities
Accrued expenses - related party
Deferred revenue
Payable to affiliate - current
Other liabilities

Net cash used in operating activities
Cash flows from investing activities:
Note receivable—related party
Purchases of property and equipment
Software development costs
Proceeds from short-term investments
Note receivable-related party
Decrease in cash (VericiDx deconsolidation)
Purchase of equipment
Net cash used in investing activities

Cash flows from financing activities:
Payment of convertible notes principal
Proceeds from convertible notes
Gross proceeds from the issuance of ordinary shares, net of underwriting fees
Payment of debt issuance costs
Payment of offering costs
Proceeds from the issuance of ordinary shares under employee share purchase plan
Proceeds from exercise of stock options
Net cash provided by financing activities
Net (decrease) increase in cash and cash equivalents
Effect of exchange rate changes on cash
Net decrease in cash and cash equivalents
Cash and cash equivalents, beginning of year
Cash and cash equivalents, end of year
Supplemental noncash investing and financing activities:
Reclassification of note receivable in Kantaro to Investment in Kantaro
Deemed distribution of VericiDx ordinary shares
Conversion of distribution of VericiDx note receivable into VericiDx ordinary shares
Noncash lease liabilities arising from obtaining right-of-use assets
Cash paid for interest on convertible debt
Issuance of shares for debt repayment

Comments